Trovagene Investor Relations http://trovagene.investorroom.com/ Trovagene Investor Relations Trovagene Announces $7.1 Million Registered Direct Offering http://trovagene.investorroom.com/2017-07-14-Trovagene-Announces-7-1-Million-Registered-Direct-Offering Fri, 14 Jul 2017 06:00:00 -0700 http://trovagene.investorroom.com/2017-07-14-Trovagene-Announces-7-1-Million-Registered-Direct-Offering Trovagene Announces Agreement with Novogene for NextCollectâ„¢ in China http://trovagene.investorroom.com/2017-07-12-Trovagene-Announces-Agreement-with-Novogene-for-NextCollect-TM-in-China Wed, 12 Jul 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-07-12-Trovagene-Announces-Agreement-with-Novogene-for-NextCollect-TM-in-China Trovagene, Inc. Regains Compliance with NASDAQ Listing Requirements http://trovagene.investorroom.com/2017-07-10-Trovagene-Inc-Regains-Compliance-with-NASDAQ-Listing-Requirements Mon, 10 Jul 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-07-10-Trovagene-Inc-Regains-Compliance-with-NASDAQ-Listing-Requirements Trovagene Engages Leading CRO in AML to Conduct Phase 1b/2 Trial of PCM-075 http://trovagene.investorroom.com/2017-07-06-Trovagene-Engages-Leading-CRO-in-AML-to-Conduct-Phase-1b-2-Trial-of-PCM-075 Thu, 06 Jul 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-07-06-Trovagene-Engages-Leading-CRO-in-AML-to-Conduct-Phase-1b-2-Trial-of-PCM-075 Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial http://trovagene.investorroom.com/2017-06-29-Trovagene-Announces-Manufacturing-Agreement-with-NerPharMa-for-Supply-of-PCM-075-for-AML-Trial Thu, 29 Jun 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-06-29-Trovagene-Announces-Manufacturing-Agreement-with-NerPharMa-for-Supply-of-PCM-075-for-AML-Trial